HHS director of communications Andrew Nixon confirmed Thursday the meeting was postponed, and the ACIP meetings website also ...
Despite more than 50 years of research, there are no RSV vaccines approved or in Phase III clinical trials. Key challenges include peak disease in infants less than 3 months of age and ...
The program offered a free RSV vaccine to adults aged 75–79, including those turning 75 before July 2025. By the end of November 2024, 68% of eligible people had received the vaccine ...
On September 1, the RSV Immunisation Pathfinder Programme commenced. Running until the end of February 2025, the provisional initiative sees all babies born within that period being offered a new ...
The Public Health Agency of Canada said Wednesday it's purchased 500,000 doses of a human vaccine to protect against avian influenza for those most at risk from being exposed to the virus by ...
The respiratory syncytial virus vaccine Ad26/protein preF was associated with robust humoral and cellular immune responses among healthy and high-risk younger adults. A respiratory syncytial virus ...
But it's Robert F. Kennedy Jr.'s comments about the childhood vaccine schedule that are getting the most attention, telling HHS employees *** new commission created by President Donald Trump will ...
The surge in flu cases also comes amid concerns about high infection rates for other viruses including RSV, COVID-19 and the gastrointestinal bug norovirus. Still, health officials say flu cases ...
High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants. The rollout of 2 major interventions to prevent severe respiratory syncytial virus (RSV ...
Canada’s colder weather goes hand-in-hand with respiratory virus season, with flu, RSV and COVID-19 circulating. While Canadians learned a lot about how to protect themselves from illness during ...
Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., particularly those 60 and older. Before respiratory syncytial virus (RSV) ...
Vaccines are a clinical product that is composed of live or dead material from an infectious agent – bacterium, virus, fungus or parasite – that elicit protective immunity against the pathogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results